HomeEndomag

Endomag

University Hospitals System Adopts Magseed Marker as Standard of Care for Localization of Impalpable Breast Lesions

Endomag, the surgical guidance company, announced today that University Hospitals (UH), one of the leading healthcare systems in the US, providing high-quality, patient-centred cancer care at locations throughout Northeast Ohio, has expanded the use of its Magseed®...

Endomag’s Magseed Marker Receives FDA Clearance for Long-Term and Soft Tissue Implantation

2/22/18: Endomag, the surgical guidance company, announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to extend the indication of its Magseed® magnetic marker to include both the marking of soft tissue and long-term implantation.

Ochsner Health System adopts Magseed® as Standard of Care for Localization of Impalpable Breast Lesions

Magseed technology guides surgeons during a breast lumpectomy to simplify treatment and improve patient experience Endomag, the cancer healthcare company, announced today that Ochsner Health System has adopted Magseed® as the standard of care for breast lesion localization,...